CLINICAL_TRIALS
trial_result
· 2023-09-28
Clinical Trial Update: Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial results for MEDI3506 in adults with atopic dermatitis have been completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28